KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $21.39 $29.07 Friday, 26th Apr 2024 ARWR stock ended at $22.12. This is 1.14% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.95% from a day low at $21.72 to a day high of $22.36.
90 days $21.39 $36.72
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Jan 13, 2021 $82.11 $84.55 $80.89 $81.00 709 162
Jan 12, 2021 $80.42 $82.93 $80.01 $82.69 550 420
Jan 11, 2021 $79.00 $81.22 $78.03 $80.11 829 304
Jan 08, 2021 $78.85 $82.25 $78.10 $79.88 937 060
Jan 07, 2021 $75.00 $79.49 $75.00 $79.47 971 115
Jan 06, 2021 $71.62 $74.74 $70.11 $74.38 1 709 559
Jan 05, 2021 $74.57 $74.57 $70.45 $72.63 1 264 436
Jan 04, 2021 $76.07 $77.11 $74.52 $74.83 1 161 508
Dec 31, 2020 $77.81 $77.87 $75.68 $76.73 677 682
Dec 30, 2020 $78.78 $81.28 $77.29 $77.43 681 618
Dec 29, 2020 $79.71 $79.95 $75.25 $78.04 833 771
Dec 28, 2020 $85.35 $85.78 $79.75 $79.94 840 720
Dec 24, 2020 $84.92 $86.75 $83.62 $84.19 313 137
Dec 23, 2020 $82.83 $86.11 $81.74 $85.37 730 123
Dec 22, 2020 $82.67 $83.90 $80.82 $82.83 1 019 138
Dec 21, 2020 $77.03 $82.06 $74.62 $82.03 1 407 637
Dec 18, 2020 $79.97 $82.06 $79.05 $80.16 2 966 977
Dec 17, 2020 $76.96 $79.70 $76.89 $79.37 872 247
Dec 16, 2020 $76.92 $77.96 $74.95 $77.63 835 391
Dec 15, 2020 $75.75 $77.20 $74.81 $76.45 884 033
Dec 14, 2020 $74.68 $78.27 $74.68 $74.91 1 166 700
Dec 11, 2020 $73.64 $75.03 $72.66 $74.06 1 007 921
Dec 10, 2020 $68.49 $74.11 $68.14 $74.01 1 337 567
Dec 09, 2020 $68.66 $72.17 $67.98 $68.90 1 438 757
Dec 08, 2020 $66.17 $68.34 $65.70 $68.18 690 436
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT